FILE - In this Nov. 10, 2016, file photo, a name of Samsung Biologics Co. is displayed at the Korea Exchange in Seoul, South Korea. A South Korean regulator says Samsung Biologics has intentionally breached accounting rules. The Financial Services Commission said Thursday, July 13, 2018, that it will bring the case to prosecutors and ask Samsung Biologics to dismiss executives in charge of accounting breaches.(AP Photo/Lee Jin-man, File)
FILE - In this Nov. 10, 2016, file photo, a name of Samsung Biologics Co. is displayed at the Korea Exchange in Seoul, South Korea. A South Korean regulator says Samsung Biologics has intentionally breached accounting rules. The Financial Services Commission said Thursday, July 13, 2018, that it will bring the case to prosecutors and ask Samsung Biologics to dismiss executives in charge of accounting breaches.(AP Photo/Lee Jin-man, File) Lee Jin-man AP
FILE - In this Nov. 10, 2016, file photo, a name of Samsung Biologics Co. is displayed at the Korea Exchange in Seoul, South Korea. A South Korean regulator says Samsung Biologics has intentionally breached accounting rules. The Financial Services Commission said Thursday, July 13, 2018, that it will bring the case to prosecutors and ask Samsung Biologics to dismiss executives in charge of accounting breaches.(AP Photo/Lee Jin-man, File) Lee Jin-man AP

Samsung Biologics to face criminal probe on accounting fraud

July 12, 2018 06:15 AM